Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

In a report released today, Jade Rahmani from KBW maintained a Buy rating on Kkr Real Estate Finance (KREF – Research Report), with a price ...

Q4 2024 Earnings Call Transcript February 4, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.32, ...

With England and India are playing their first ODI match at the Vidarbha Cricket Association Stadium in Nagpur on February 6, ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.

Indian pacer Harshit Rana, 23, debuted in One Day Internationals (ODIs) in the opening game of the three-match series against ...

XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the ...

CENTRAL TRUST Co increased its position in KKR & Co. Inc. (NYSE:KKR – Free Report) by 27.0% in the 4th quarter, according to ...

KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...

The two US banks’ role in the bid would be to refinance the debt of Seven & i’s US unit, one of the people said. The company ...

Chakravarthy made a comeback to the Indian unit in the home series against Bangladesh in October 2024 and is the leading ...